Division of Cancer Medicine (KRE)
The Division of Cancer Medicine is one of 15 clinics at the Institute of Clinical Medicine, with around 70 employees. They contribute in the teaching of medical students, among others, and conduct research, dissemination and innovation.
The Division has activities at Radiumhospitalet, Rikshospitalet, Ullevål and Aker Hospital.
The research is organised into 53 research groups. About 30 doctoral degrees are awarded annually in the clinic. The research activities include clinical, translational and explanatory research, and a clinical trial unit.
The Center for Cancer Biomedicine (CCB) was replaced by the Center for Cancer Cell Reprogramming (CanCell) from 2018. The Division also hosts the K.G.Jebsen Center for Immunotherapy.
A number of regional core research facilities are run in the clinic:
Bioinformatics, confocal microscopy, electron microscopy, flow cytometry, proteomics, microarray and sequencing, genotyping, comparative medicine, and animal MRI.
The Division is co-located with, and a member of, the innovation cluster Oslo Cancer Cluster, and students from Ullern High School do practice at the Institute of Cancer Research. The division is also host to Oslo University Hospital Comprehensive Cancer Center (OUS-CCC).
Researcher groups at KRE
Overview of the division's research groups (Norwegian)
The group overview is divided according to department affiliation.
- Department of Gynaecological Oncology
- Department of Haematology
- Department of Oncology
- Forskningsleder KRE